The data of this study showed that the levels of CRP, IL-6, and TNF-α in the observation group after treatment were significantly lower than those before treatment, indicating that atorvastatin could help to control the inflammatory reaction of DN patients. Here, IL6 is linked to liver dysplastic nodule.